11β-hydroxylase deficiency surgery: Difference between revisions
No edit summary |
No edit summary |
||
| Line 5: | Line 5: | ||
The predominant therapy for ambigous genitalia in congenital adrenal hyperplasia due to 11β-hydroxylase deficiency is surgical correction. | The predominant therapy for ambigous genitalia in congenital adrenal hyperplasia due to 11β-hydroxylase deficiency is surgical correction. | ||
==Surgery== | ==Surgery== | ||
* Suregry is used to correct ambigous genitalia. | * Suregry is used to correct ambigous genitalia.<ref> Congenital adrenal hyperplasia due to 11β-hydroxylase deficiency. Wikipedia (2016). https://en.wikipedia.org/wiki/Congenital_adrenal_hyperplasia_due_to_11%CE%B2-hydroxylase_deficiency Accessed on January 29, 2016</ref> | ||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
Revision as of 20:45, 29 January 2016
|
Congenital adrenal hyperplasia due to 11β-hydroxylase deficiency Microchapters |
|
Differentiating Congenital adrenal hyperplasia due to 11β-hydroxylase deficiency from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
11β-hydroxylase deficiency surgery On the Web |
|
American Roentgen Ray Society Images of 11β-hydroxylase deficiency surgery |
|
Directions to Hospitals Treating Congenital adrenal hyperplasia due to 11β-hydroxylase deficiency |
|
Risk calculators and risk factors for 11β-hydroxylase deficiency surgery |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ammu Susheela, M.D. [2]
Overview
The predominant therapy for ambigous genitalia in congenital adrenal hyperplasia due to 11β-hydroxylase deficiency is surgical correction.
Surgery
- Suregry is used to correct ambigous genitalia.[1]
References
- ↑ Congenital adrenal hyperplasia due to 11β-hydroxylase deficiency. Wikipedia (2016). https://en.wikipedia.org/wiki/Congenital_adrenal_hyperplasia_due_to_11%CE%B2-hydroxylase_deficiency Accessed on January 29, 2016